positionForPages[216]={page:216,positions:[{w:"Summary",p:[0.117647,0.126494,0.214362,0.126494,0.214362,0.098384,0.117647,0.098384,0.012144,0.013015,0.017286,0.017286,0.012318,0.012638,0.012028]},{w:"Cancer genomics is a thriving field with constant methodological and technological ",p:[0.117647,0.171137,0.857144,0.171137,0.857144,0.150764,0.117647,0.150764,0.014974,0.009085,0.011596,0.008994,0.009039,0.007807,0.007578,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.007670,0.007578,0.005615,0.007670,0.007578,0.009291,0.007578,0.006620,0.011459,0.007807,0.005547,0.009838,0.005615,0.011459,0.009861,0.007578,0.005684,0.005615,0.008948,0.005182,0.011391,0.007578,0.014723,0.005273,0.006620,0.011459,0.007578,0.008994,0.010843,0.011619,0.007510,0.006551,0.009085,0.011391,0.006437,0.007578,0.017485,0.009131,0.006620,0.011299,0.011276,0.011322,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.007578,0.009085,0.011596,0.011391,0.007578,0.006209,0.009108,0.008765,0.011459,0.011596,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.004109]},{w:"advances. These developments enable personalized and targeted treatments for cancer ",p:[0.117647,0.191716,0.857052,0.191716,0.857052,0.171343,0.117647,0.171343,0.009291,0.011322,0.009838,0.009085,0.011596,0.008994,0.009039,0.007670,0.004497,0.005798,0.011470,0.011311,0.009039,0.007875,0.009039,0.005798,0.011322,0.009336,0.009633,0.008948,0.005182,0.010820,0.011071,0.017485,0.009039,0.011391,0.006437,0.007670,0.005798,0.009039,0.011687,0.009108,0.010911,0.005182,0.009039,0.005798,0.011502,0.009039,0.007626,0.007873,0.010843,0.011690,0.009402,0.005250,0.005615,0.008834,0.009108,0.011391,0.005798,0.009085,0.011596,0.011391,0.005798,0.006551,0.009085,0.007624,0.009656,0.009131,0.006209,0.009108,0.011391,0.005798,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.007670,0.005798,0.006029,0.010840,0.007807,0.005798,0.009108,0.009085,0.011598,0.008994,0.009039,0.007807,0.004109]},{w:"patients based on the unique genomic profiles of tumors. In this thesis I leveraged novel ",p:[0.117647,0.212294,0.857032,0.212294,0.857032,0.191922,0.117647,0.191922,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004269,0.011117,0.009291,0.007875,0.009108,0.011391,0.004269,0.010843,0.011756,0.004269,0.006620,0.011299,0.009039,0.004269,0.011413,0.011756,0.005547,0.010706,0.011345,0.009039,0.004269,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.004269,0.011073,0.007442,0.010843,0.005684,0.005819,0.005182,0.009039,0.007670,0.004269,0.010843,0.006209,0.004269,0.006163,0.011413,0.017485,0.010843,0.007624,0.007670,0.004497,0.004269,0.006894,0.011756,0.004269,0.006620,0.011459,0.005615,0.007670,0.004269,0.006620,0.011302,0.009039,0.007601,0.005615,0.007670,0.004269,0.007259,0.004269,0.005182,0.009336,0.009633,0.009039,0.007898,0.009199,0.009656,0.009108,0.011391,0.004269,0.011596,0.010866,0.009633,0.008948,0.005250,0.004109]},{w:"technologies for the advancement of cancer research and care. In ",p:[0.117647,0.232873,0.662043,0.232873,0.662043,0.212500,0.117647,0.212500,0.006209,0.009108,0.008765,0.011459,0.011596,0.010934,0.005182,0.011048,0.009861,0.005547,0.009039,0.007670,0.004004,0.006026,0.010843,0.007807,0.004006,0.006620,0.011299,0.009039,0.004004,0.009291,0.011322,0.009838,0.009085,0.011596,0.008994,0.009039,0.017485,0.009039,0.011391,0.006437,0.004006,0.010843,0.006209,0.004004,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.004006,0.007442,0.009039,0.007875,0.009288,0.009087,0.007442,0.008765,0.011459,0.004004,0.009085,0.011596,0.011391,0.004006,0.009108,0.009085,0.007442,0.008743,0.004497,0.004004,0.006894,0.011756,0.004109]},{w:"chapter 1",p:[0.661940,0.232873,0.743626,0.232873,0.743626,0.211740,0.661940,0.211740,0.009085,0.011779,0.009542,0.011733,0.006871,0.009268,0.008583,0.003915,0.010911]},{w:" I introduced ",p:[0.743627,0.232873,0.857051,0.232873,0.857051,0.212500,0.743627,0.212500,0.004006,0.007259,0.004004,0.005615,0.011391,0.006437,0.007442,0.011276,0.011048,0.011345,0.008994,0.009108,0.011391,0.004109]},{w:"the different types of genomic variation, the genomic characteristics of cancer, the im-",p:[0.117647,0.253452,0.852941,0.253452,0.852941,0.233079,0.117647,0.233079,0.006620,0.011299,0.009039,0.005593,0.011391,0.005615,0.005969,0.005784,0.009039,0.007442,0.009039,0.011391,0.006437,0.005593,0.006437,0.009724,0.011505,0.009039,0.007670,0.005593,0.010843,0.006209,0.005593,0.009656,0.009039,0.011598,0.010840,0.017645,0.005547,0.008994,0.005593,0.009838,0.009085,0.007807,0.005798,0.008811,0.006437,0.005547,0.010843,0.011756,0.004497,0.005593,0.006620,0.011299,0.009039,0.005593,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.005593,0.008765,0.011391,0.009085,0.007898,0.009291,0.009108,0.006209,0.009039,0.007807,0.005615,0.007510,0.006437,0.005547,0.008994,0.007670,0.005593,0.010845,0.006209,0.005593,0.009108,0.009085,0.011596,0.008994,0.009039,0.006255,0.004497,0.005593,0.006620,0.011299,0.009039,0.005593,0.005615,0.017574,0.007533]},{w:"portance of genomic technology for personalized medicine and the potential of liquid ",p:[0.117647,0.274031,0.856959,0.274031,0.856959,0.253658,0.117647,0.253658,0.011505,0.010843,0.007967,0.006551,0.009085,0.011596,0.008994,0.009039,0.005570,0.010845,0.006209,0.005570,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.005570,0.006209,0.009108,0.008765,0.011459,0.011596,0.010934,0.005182,0.011048,0.010546,0.009724,0.005570,0.006026,0.010843,0.007807,0.005570,0.011505,0.009039,0.007624,0.007875,0.010843,0.011687,0.009405,0.005250,0.005615,0.008834,0.009108,0.011391,0.005570,0.017488,0.009106,0.011391,0.005547,0.008994,0.005615,0.011596,0.009039,0.005570,0.009085,0.011596,0.011391,0.005570,0.006620,0.011299,0.009039,0.005570,0.011502,0.010820,0.006209,0.009039,0.011391,0.006437,0.005796,0.009405,0.005250,0.005570,0.010843,0.006209,0.005570,0.005250,0.005549,0.010703,0.011413,0.005547,0.011391,0.004109]},{w:"biopsies for low-invasive cancer monitoring. I also introduced model systems used in ",p:[0.117647,0.294609,0.857027,0.294609,0.857027,0.274236,0.117647,0.274236,0.010820,0.005547,0.010820,0.011185,0.007601,0.005547,0.009039,0.007670,0.006118,0.006026,0.010843,0.007807,0.006118,0.005182,0.010866,0.014723,0.007533,0.005615,0.011365,0.009838,0.009291,0.007604,0.005547,0.009633,0.009039,0.006118,0.009106,0.009087,0.011596,0.008994,0.009039,0.007807,0.006118,0.017488,0.010843,0.011756,0.005271,0.006211,0.010843,0.007807,0.005615,0.011459,0.009676,0.004497,0.006118,0.007259,0.006118,0.009405,0.005250,0.007875,0.011048,0.006118,0.005615,0.011391,0.006437,0.007442,0.011276,0.011048,0.011345,0.008994,0.009108,0.011391,0.006118,0.017485,0.011276,0.011322,0.008948,0.005250,0.006118,0.007761,0.009724,0.007510,0.006209,0.009039,0.017508,0.007670,0.006118,0.011413,0.007873,0.009108,0.011391,0.006118,0.005615,0.011756,0.004109]},{w:"cancer research, including patient-derived organoids (PDOs), detailing the potential for ",p:[0.117647,0.315188,0.857075,0.315188,0.857075,0.294815,0.117647,0.294815,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.004154,0.007442,0.009039,0.007875,0.009291,0.009085,0.007442,0.008765,0.011459,0.004497,0.004154,0.005615,0.011596,0.008765,0.004908,0.011345,0.011391,0.005615,0.011459,0.009861,0.004154,0.011365,0.008813,0.006437,0.005545,0.009039,0.011391,0.006437,0.007533,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.004154,0.010843,0.007624,0.009861,0.009085,0.011596,0.010843,0.005547,0.011391,0.007670,0.004154,0.006939,0.011664,0.016504,0.016253,0.007670,0.006939,0.004497,0.004154,0.011322,0.009131,0.006551,0.009085,0.005752,0.005250,0.005615,0.011459,0.009861,0.004154,0.006620,0.011302,0.009039,0.004154,0.011505,0.010820,0.006209,0.009039,0.011391,0.006437,0.005798,0.009405,0.005250,0.004154,0.006026,0.010843,0.007807,0.004109]},{w:"their use particularly in ovarian cancer (OC). Lastly, I introduced the role of somatic SV ",p:[0.117647,0.335767,0.857009,0.335767,0.857009,0.315394,0.117647,0.315394,0.006620,0.011299,0.009039,0.005615,0.007807,0.004223,0.011413,0.007875,0.009039,0.004223,0.011365,0.009085,0.007967,0.006437,0.005547,0.009108,0.011550,0.005433,0.009085,0.007601,0.005182,0.009724,0.004223,0.005615,0.011756,0.004223,0.010866,0.009838,0.009085,0.007807,0.005798,0.009085,0.011756,0.004223,0.009108,0.009087,0.011596,0.008994,0.009039,0.007807,0.004223,0.006939,0.016778,0.014678,0.006939,0.004497,0.004223,0.011984,0.009291,0.007510,0.006620,0.005182,0.007989,0.004497,0.004223,0.007259,0.004223,0.005615,0.011391,0.006437,0.007442,0.011276,0.011048,0.011345,0.008994,0.009108,0.011391,0.004223,0.006620,0.011302,0.009039,0.004223,0.007442,0.010934,0.005182,0.009039,0.004223,0.010843,0.006209,0.004223,0.007875,0.010843,0.017577,0.008811,0.006437,0.005547,0.008994,0.004223,0.010112,0.015089,0.004109]},{w:"in cancer and the different sequencing technologies that are used to detect them, along ",p:[0.117647,0.356345,0.857121,0.356345,0.857121,0.335972,0.117647,0.335972,0.005615,0.011756,0.005090,0.009106,0.009085,0.011598,0.008994,0.009039,0.007807,0.005090,0.009085,0.011596,0.011391,0.005090,0.006620,0.011299,0.009039,0.005090,0.011391,0.005615,0.005969,0.005787,0.009039,0.007442,0.009039,0.011391,0.006437,0.005090,0.007875,0.009108,0.010706,0.011345,0.009039,0.011596,0.008994,0.005615,0.011459,0.009861,0.005090,0.006209,0.009108,0.008765,0.011459,0.011596,0.010934,0.005182,0.011048,0.009861,0.005547,0.009039,0.007670,0.005090,0.006620,0.011391,0.008811,0.006437,0.005090,0.009085,0.007442,0.009039,0.005090,0.011413,0.007875,0.009108,0.011391,0.005090,0.006209,0.011048,0.005090,0.011322,0.009131,0.006209,0.009108,0.009108,0.006437,0.005090,0.006620,0.011299,0.009039,0.017645,0.004497,0.005090,0.009405,0.005182,0.010843,0.011459,0.009861,0.004109]},{w:"with the challenges that this presents. ",p:[0.117647,0.376924,0.433408,0.376924,0.433408,0.356551,0.117647,0.356551,0.014723,0.005273,0.006620,0.011459,0.004109,0.006620,0.011299,0.009039,0.004109,0.008765,0.011391,0.009405,0.005385,0.005182,0.009039,0.011461,0.009656,0.009039,0.007670,0.004109,0.006617,0.011391,0.008813,0.006437,0.004109,0.006617,0.011459,0.005615,0.007670,0.004109,0.011071,0.007442,0.009039,0.007875,0.009039,0.011391,0.006437,0.007670,0.004497,0.004109]},{w:"In the first part of this thesis, we used organoid technology to advance OC research. In ",p:[0.117647,0.418081,0.857029,0.418081,0.857029,0.397709,0.117647,0.397709,0.006894,0.011756,0.004999,0.006620,0.011299,0.009039,0.004999,0.005684,0.005684,0.007624,0.007510,0.006437,0.004999,0.011368,0.009085,0.007967,0.006437,0.004999,0.010843,0.006209,0.004999,0.006620,0.011459,0.005615,0.007670,0.004999,0.006620,0.011302,0.009039,0.007601,0.005615,0.007670,0.004497,0.004999,0.014518,0.009039,0.004999,0.011413,0.007875,0.009106,0.011391,0.004999,0.010843,0.007624,0.009861,0.009085,0.011596,0.010843,0.005547,0.011391,0.004999,0.006209,0.009108,0.008765,0.011459,0.011596,0.010934,0.005182,0.011048,0.010546,0.009724,0.004999,0.006209,0.011048,0.004999,0.009291,0.011322,0.009838,0.009085,0.011596,0.008994,0.009039,0.004999,0.016778,0.014678,0.004999,0.007442,0.009039,0.007875,0.009291,0.009085,0.007442,0.008765,0.011459,0.004497,0.004999,0.006894,0.011756,0.004109]},{w:"chapter 2",p:[0.117647,0.438660,0.200942,0.438660,0.200942,0.417527,0.117647,0.417527,0.009085,0.011779,0.009542,0.011733,0.006871,0.009268,0.008583,0.005524,0.010911]},{w:" we established and characterized a PDO biobank that faithfully represented ",p:[0.200938,0.438660,0.856975,0.438660,0.856975,0.418287,0.200938,0.418287,0.005638,0.014518,0.009039,0.005638,0.009039,0.007510,0.006549,0.009108,0.010911,0.005250,0.005615,0.007556,0.011302,0.009106,0.011391,0.005638,0.009085,0.011596,0.011391,0.005638,0.008765,0.011391,0.009085,0.007898,0.009291,0.009108,0.006209,0.009039,0.007807,0.005615,0.008834,0.009106,0.011391,0.005638,0.009291,0.005638,0.011664,0.016504,0.016412,0.005638,0.010820,0.005547,0.010957,0.011117,0.009085,0.011870,0.010523,0.005638,0.006620,0.011391,0.008811,0.006437,0.005638,0.006209,0.009085,0.005273,0.006620,0.011459,0.006369,0.011550,0.005385,0.005184,0.009724,0.005638,0.007442,0.009131,0.011071,0.007442,0.009039,0.007875,0.009039,0.011391,0.006209,0.009108,0.011391,0.004109]},{w:"the disease, and presented its applications. The biobank consisted of 56 PDO lines from ",p:[0.117647,0.459239,0.857048,0.459239,0.857048,0.438866,0.117647,0.438866,0.006620,0.011299,0.009039,0.004520,0.011391,0.005615,0.007875,0.009291,0.009291,0.007873,0.008743,0.004497,0.004520,0.009087,0.011596,0.011391,0.004520,0.011071,0.007442,0.009039,0.007875,0.009039,0.011391,0.006207,0.009108,0.011391,0.004520,0.005273,0.006437,0.007670,0.004520,0.008811,0.011048,0.011162,0.005250,0.005547,0.009108,0.008811,0.006437,0.005547,0.010843,0.011619,0.007670,0.004497,0.004520,0.011470,0.011311,0.009039,0.004520,0.010820,0.005547,0.010957,0.011117,0.009085,0.011870,0.010523,0.004520,0.008994,0.010843,0.011619,0.007601,0.005615,0.007510,0.006209,0.009108,0.011391,0.004520,0.010843,0.006209,0.004520,0.010432,0.010432,0.004520,0.011664,0.016501,0.016412,0.004520,0.005250,0.005615,0.011596,0.009039,0.007670,0.004520,0.006414,0.007442,0.010843,0.017645,0.004109]},{w:"32 patients and included all the main histological subtypes of OC. We characterized the ",p:[0.117647,0.479818,0.856981,0.479818,0.856981,0.459445,0.117647,0.459445,0.010432,0.010432,0.004474,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004474,0.009085,0.011596,0.011391,0.004474,0.005615,0.011596,0.008765,0.004908,0.011345,0.011322,0.009108,0.011391,0.004474,0.009405,0.005387,0.005250,0.004474,0.006620,0.011299,0.009039,0.004474,0.017577,0.009085,0.005615,0.011756,0.004474,0.011459,0.005615,0.007508,0.006211,0.010932,0.005184,0.011048,0.009861,0.005545,0.009108,0.009405,0.005250,0.004474,0.007512,0.011345,0.010797,0.006437,0.009724,0.011502,0.009039,0.007670,0.004474,0.010843,0.006209,0.004474,0.016778,0.014678,0.004497,0.004474,0.018649,0.009039,0.004474,0.008765,0.011391,0.009085,0.007898,0.009291,0.009108,0.006209,0.009039,0.007807,0.005615,0.008834,0.009108,0.011391,0.004474,0.006620,0.011299,0.009039,0.004109]},{w:"organoid lines at the histopathological, genomic and epigenomic levels and showed how ",p:[0.117647,0.500396,0.857118,0.500396,0.857118,0.480023,0.117647,0.480023,0.010843,0.007624,0.009861,0.009085,0.011596,0.010843,0.005547,0.011391,0.003881,0.005250,0.005615,0.011596,0.009039,0.007670,0.003881,0.008811,0.006437,0.003881,0.006620,0.011299,0.009039,0.003881,0.011459,0.005615,0.007510,0.006209,0.010820,0.011365,0.008813,0.006617,0.011299,0.010936,0.005182,0.011048,0.009861,0.005545,0.009108,0.009405,0.004976,0.004497,0.003881,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.003881,0.009085,0.011596,0.011391,0.003881,0.009131,0.011071,0.005615,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.003881,0.005182,0.009336,0.009633,0.008948,0.005250,0.007670,0.003881,0.009085,0.011596,0.011391,0.003881,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.003881,0.011299,0.010866,0.014723,0.004109]},{w:"these lines faithfully recapitulated the original tumors. We also demonstrated that these ",p:[0.117647,0.520975,0.857096,0.520975,0.857096,0.500602,0.117647,0.500602,0.006620,0.011299,0.009039,0.007875,0.009039,0.004645,0.005250,0.005615,0.011596,0.009039,0.007670,0.004657,0.006209,0.009085,0.005273,0.006620,0.011459,0.006366,0.011550,0.005387,0.005182,0.009724,0.004657,0.007442,0.009108,0.009108,0.008809,0.011071,0.005273,0.006163,0.011550,0.005433,0.008811,0.006209,0.009108,0.011391,0.004657,0.006620,0.011299,0.009039,0.004645,0.010843,0.007807,0.005615,0.009861,0.005615,0.011687,0.009405,0.005250,0.004645,0.006166,0.011413,0.017485,0.010843,0.007624,0.007670,0.004497,0.004645,0.018649,0.009039,0.004645,0.009405,0.005250,0.007875,0.011048,0.004657,0.011322,0.009039,0.017485,0.010843,0.011619,0.007510,0.006437,0.007898,0.008811,0.006209,0.009108,0.011391,0.004645,0.006620,0.011391,0.008811,0.006437,0.004657,0.006620,0.011299,0.009039,0.007875,0.009039,0.004109]},{w:"characteristics were maintained over time and extensive culturing. Furthermore, tran-",p:[0.117647,0.541554,0.852941,0.541554,0.852941,0.521181,0.117647,0.521181,0.008765,0.011391,0.009085,0.007898,0.009291,0.009108,0.006209,0.009039,0.007807,0.005615,0.007510,0.006437,0.005547,0.008994,0.007670,0.005912,0.014518,0.009039,0.007442,0.009039,0.005912,0.017577,0.009085,0.005615,0.011391,0.006551,0.009085,0.005615,0.011596,0.009108,0.011391,0.005912,0.010866,0.009633,0.009039,0.007807,0.005912,0.006437,0.005615,0.017485,0.009039,0.005912,0.009085,0.011596,0.011391,0.005912,0.009108,0.010089,0.006209,0.009039,0.011619,0.007601,0.005547,0.009633,0.009039,0.005912,0.009108,0.011550,0.004908,0.006163,0.011413,0.007807,0.005615,0.011459,0.009679,0.004497,0.005912,0.010729,0.011413,0.007967,0.006620,0.011299,0.009039,0.007807,0.017485,0.010843,0.007442,0.008743,0.004497,0.005912,0.006437,0.007898,0.009087,0.011751,0.007533]},{w:"scriptomic analysis showed that the PDO lines from the different OC subtypes clustered ",p:[0.117647,0.562132,0.857007,0.562132,0.857007,0.541759,0.117647,0.541759,0.007875,0.008994,0.007807,0.005273,0.011048,0.006209,0.010843,0.017645,0.005547,0.008994,0.003972,0.009085,0.011687,0.009405,0.005182,0.009724,0.007601,0.005615,0.007670,0.003972,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.003972,0.006617,0.011393,0.008811,0.006437,0.003972,0.006620,0.011299,0.009039,0.003972,0.011664,0.016504,0.016412,0.003972,0.005250,0.005615,0.011596,0.009039,0.007670,0.003972,0.006414,0.007442,0.010843,0.017645,0.003972,0.006620,0.011299,0.009039,0.003972,0.011391,0.005615,0.005969,0.005787,0.009039,0.007442,0.009039,0.011391,0.006437,0.003972,0.016778,0.014678,0.003972,0.007510,0.011345,0.010797,0.006437,0.009724,0.011505,0.009039,0.007670,0.003972,0.008765,0.004908,0.011413,0.007510,0.006209,0.009039,0.007442,0.009108,0.011391,0.004109]},{w:"together based on expression patterns. Intra- and inter-patient heterogeneity was repre-",p:[0.117647,0.582711,0.852941,0.582711,0.852941,0.562338,0.117647,0.562338,0.006209,0.011048,0.009656,0.009131,0.006620,0.011299,0.009039,0.007807,0.004406,0.011117,0.009291,0.007875,0.009108,0.011391,0.004406,0.010840,0.011756,0.004406,0.009108,0.010089,0.011069,0.007442,0.009039,0.007533,0.007601,0.005547,0.010843,0.011756,0.004406,0.011368,0.008811,0.006163,0.006209,0.009039,0.007807,0.011619,0.007670,0.004497,0.004406,0.006894,0.011391,0.006437,0.007898,0.009291,0.007533,0.004406,0.009085,0.011598,0.011391,0.004406,0.005615,0.011391,0.006209,0.009039,0.007236,0.007533,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.004406,0.011299,0.009131,0.006209,0.009039,0.007442,0.011048,0.009656,0.009039,0.011596,0.009039,0.005273,0.006437,0.009724,0.004406,0.014723,0.009291,0.007670,0.004406,0.007442,0.009131,0.011071,0.007442,0.009039,0.007533]},{w:"sented in the biobank. We also presented proof-of-concept for drug screening studies ",p:[0.117647,0.603290,0.857002,0.603290,0.857002,0.582917,0.117647,0.582917,0.007875,0.009039,0.011391,0.006209,0.009108,0.011391,0.006049,0.005615,0.011756,0.006049,0.006620,0.011299,0.009039,0.006049,0.010820,0.005547,0.010957,0.011117,0.009085,0.011870,0.010523,0.004497,0.006049,0.018649,0.009039,0.006049,0.009402,0.005250,0.007875,0.011048,0.006049,0.011071,0.007442,0.009039,0.007875,0.009039,0.011391,0.006209,0.009108,0.011391,0.006049,0.011071,0.007442,0.011276,0.010843,0.006209,0.007533,0.010843,0.006209,0.007533,0.008994,0.010840,0.011596,0.008994,0.009131,0.011048,0.006437,0.006049,0.006026,0.010843,0.007807,0.006049,0.011391,0.007967,0.011413,0.009861,0.006049,0.007875,0.008994,0.007442,0.009108,0.009039,0.011756,0.005615,0.011459,0.009861,0.006049,0.007510,0.006163,0.011345,0.011391,0.005547,0.009039,0.007670,0.004109]},{w:"with these PDOs, with different subtype responses to platinum-based chemotherapy. ",p:[0.117647,0.623869,0.857107,0.623869,0.857107,0.603496,0.117647,0.603496,0.014723,0.005273,0.006620,0.011459,0.006837,0.006620,0.011299,0.009039,0.007875,0.009039,0.006848,0.011664,0.016504,0.016253,0.007670,0.004497,0.006848,0.014723,0.005271,0.006620,0.011459,0.006848,0.011391,0.005615,0.005969,0.005787,0.009039,0.007442,0.009039,0.011391,0.006437,0.006837,0.007512,0.011345,0.010797,0.006437,0.009724,0.011502,0.009039,0.006848,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.007670,0.006848,0.006209,0.011048,0.006837,0.011162,0.005433,0.008811,0.006437,0.005615,0.011391,0.011413,0.017645,0.007533,0.011117,0.009291,0.007875,0.009108,0.011391,0.006848,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011094,0.007989,0.004497,0.004109]},{w:"Resistance to chemotherapy in recurrent disease was also reflected in the biobank. Last-",p:[0.117647,0.644447,0.852941,0.644447,0.852941,0.624074,0.117647,0.624074,0.013696,0.009039,0.007601,0.005615,0.007510,0.006551,0.009085,0.011596,0.008994,0.009039,0.004269,0.006209,0.011048,0.004269,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011094,0.009724,0.004269,0.005615,0.011756,0.004269,0.007439,0.009108,0.009108,0.011413,0.007807,0.007442,0.009039,0.011391,0.006437,0.004269,0.011391,0.005615,0.007875,0.009291,0.009291,0.007875,0.009039,0.004257,0.014723,0.009291,0.007670,0.004269,0.009405,0.005250,0.007875,0.011048,0.004269,0.007442,0.009039,0.005638,0.005570,0.009108,0.009108,0.006209,0.009106,0.011391,0.004269,0.005615,0.011756,0.004269,0.006620,0.011299,0.009039,0.004269,0.010820,0.005547,0.010957,0.011117,0.009085,0.011870,0.010523,0.004497,0.004269,0.011982,0.009291,0.007512,0.006337,0.007533]},{w:"ly, we showed that the PDOs could be xenografted into mice for ",p:[0.117647,0.665026,0.660379,0.665026,0.660379,0.644653,0.117647,0.644653,0.005182,0.007989,0.004497,0.004622,0.014520,0.009039,0.004622,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.004622,0.006620,0.011393,0.008809,0.006437,0.004634,0.006620,0.011299,0.009039,0.004622,0.011664,0.016504,0.016253,0.007670,0.004634,0.008994,0.010820,0.011550,0.005182,0.011391,0.004622,0.011254,0.009039,0.004622,0.009884,0.009039,0.011596,0.011048,0.009861,0.007898,0.009085,0.006197,0.005969,0.009108,0.011391,0.004634,0.005615,0.011391,0.006209,0.011048,0.004622,0.017645,0.005547,0.008994,0.009039,0.004622,0.006026,0.010843,0.007807,0.004109]},{w:"in vivo",p:[0.660865,0.665026,0.715490,0.665026,0.715490,0.644443,0.660865,0.644443,0.005090,0.011299,0.004725,0.009291,0.005159,0.009131,0.009930]},{w:" drug-sensitivity ",p:[0.715490,0.665026,0.857051,0.665026,0.857051,0.644653,0.715490,0.644653,0.004622,0.011391,0.007967,0.011413,0.009861,0.007533,0.007875,0.009039,0.011619,0.007601,0.005273,0.006437,0.005547,0.009838,0.005273,0.006437,0.009724,0.004109]},{w:"assays and that PDOs were amenable to genomic modification to study tumorigenesis ",p:[0.117647,0.685605,0.857121,0.685605,0.857121,0.665232,0.117647,0.665232,0.009291,0.007533,0.007944,0.008925,0.009724,0.007670,0.005661,0.009085,0.011596,0.011391,0.005661,0.006620,0.011391,0.008811,0.006437,0.005661,0.011664,0.016504,0.016253,0.007670,0.005661,0.014518,0.009039,0.007442,0.009039,0.005661,0.009085,0.017485,0.009039,0.011687,0.009108,0.010911,0.005182,0.009039,0.005661,0.006209,0.011048,0.005661,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.005661,0.017485,0.011276,0.011391,0.005615,0.005684,0.005615,0.009108,0.008811,0.006437,0.005547,0.010843,0.011756,0.005661,0.006209,0.011048,0.005661,0.007510,0.006163,0.011345,0.011322,0.009724,0.005661,0.006163,0.011413,0.017485,0.010843,0.007807,0.005615,0.009656,0.009039,0.011596,0.009039,0.007601,0.005615,0.007670,0.004109]},{w:"(for tumorigenesis study). Overall, our results highlighted the potential of organoids to ",p:[0.117647,0.706183,0.856984,0.706183,0.856984,0.685810,0.117647,0.685810,0.006939,0.006026,0.010843,0.007807,0.005045,0.006163,0.011413,0.017485,0.010843,0.007807,0.005615,0.009656,0.009039,0.011596,0.009039,0.007601,0.005615,0.007670,0.005045,0.007512,0.006161,0.011347,0.011322,0.009724,0.006939,0.004497,0.005045,0.016892,0.009633,0.009039,0.007898,0.009405,0.005387,0.004976,0.004497,0.005045,0.010820,0.011413,0.007807,0.005045,0.007442,0.009039,0.007512,0.011548,0.004908,0.006437,0.007670,0.005045,0.011459,0.005615,0.009930,0.011573,0.005250,0.005615,0.009927,0.011094,0.006211,0.009106,0.011391,0.005045,0.006620,0.011299,0.009039,0.005045,0.011505,0.010820,0.006209,0.009039,0.011391,0.006437,0.005798,0.009405,0.005250,0.005045,0.010843,0.006209,0.005045,0.010843,0.007624,0.009861,0.009085,0.011596,0.010843,0.005547,0.011391,0.007670,0.005045,0.006209,0.011048,0.004109]},{w:"advance OC research. ",p:[0.117647,0.726762,0.305489,0.726762,0.305489,0.706389,0.117647,0.706389,0.009291,0.011322,0.009838,0.009085,0.011596,0.008994,0.009039,0.004109,0.016778,0.014678,0.004109,0.007442,0.009039,0.007875,0.009288,0.009085,0.007444,0.008765,0.011459,0.004497,0.004109]},{w:"Next, we expanded the OC-PDO biobank and used those PDOs for extensive drug ",p:[0.117647,0.767919,0.856977,0.767919,0.856977,0.747547,0.117647,0.747547,0.015522,0.009108,0.010089,0.006437,0.004497,0.007464,0.014518,0.009039,0.007464,0.009108,0.010089,0.011365,0.009087,0.011596,0.011322,0.009108,0.011391,0.007464,0.006620,0.011299,0.009039,0.007464,0.016778,0.014678,0.007533,0.011662,0.016504,0.016412,0.007464,0.010820,0.005547,0.010957,0.011114,0.009085,0.011870,0.010523,0.007464,0.009085,0.011596,0.011391,0.007464,0.011413,0.007873,0.009108,0.011391,0.007464,0.006620,0.011299,0.010957,0.007875,0.009039,0.007464,0.011664,0.016504,0.016253,0.007670,0.007464,0.006026,0.010843,0.007807,0.007464,0.009108,0.010089,0.006209,0.009039,0.011619,0.007601,0.005547,0.009633,0.009039,0.007464,0.011391,0.007967,0.011413,0.009861,0.004109]},{w:"screening in ",p:[0.117647,0.788498,0.223803,0.788498,0.223803,0.768125,0.117647,0.768125,0.007875,0.008994,0.007442,0.009108,0.009039,0.011756,0.005615,0.011459,0.009861,0.003527,0.005615,0.011756,0.004109]},{w:"chapter 3",p:[0.223222,0.788498,0.304439,0.788498,0.304439,0.767365,0.223222,0.767365,0.009085,0.011779,0.009542,0.011733,0.006871,0.009268,0.008583,0.003447,0.010911]},{w:". We performed screening assays on 36 PDO lines derived from 23 ",p:[0.304441,0.788498,0.857085,0.788498,0.857085,0.768125,0.304441,0.768125,0.004497,0.003527,0.018649,0.009039,0.003538,0.011502,0.009039,0.007807,0.006026,0.010843,0.007807,0.017485,0.009108,0.011391,0.003538,0.007873,0.008994,0.007442,0.009108,0.009039,0.011756,0.005615,0.011459,0.009861,0.003538,0.009291,0.007533,0.007944,0.008925,0.009724,0.007670,0.003527,0.010843,0.011756,0.003527,0.010432,0.010432,0.003527,0.011664,0.016504,0.016412,0.003527,0.005250,0.005615,0.011596,0.009039,0.007670,0.003538,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.003527,0.006414,0.007442,0.010843,0.017645,0.003527,0.010432,0.010432,0.004109]},{w:"patients and retrospectively compared their drug responses to clinical responses of the ",p:[0.117647,0.809077,0.856961,0.809077,0.856961,0.788704,0.117647,0.788704,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.005341,0.009085,0.011596,0.011391,0.005341,0.007442,0.009131,0.006437,0.007442,0.010957,0.007510,0.011505,0.009108,0.009108,0.006437,0.005547,0.009633,0.008948,0.005182,0.009724,0.005341,0.008994,0.010843,0.017280,0.011368,0.009085,0.007442,0.009108,0.011391,0.005341,0.006620,0.011299,0.009039,0.005615,0.007807,0.005341,0.011391,0.007967,0.011413,0.009861,0.005341,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.007670,0.005341,0.006209,0.011048,0.005341,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.005341,0.007444,0.009039,0.007510,0.011502,0.010845,0.011619,0.007873,0.009039,0.007670,0.005341,0.010843,0.006209,0.005341,0.006620,0.011299,0.009039,0.004109]},{w:"patients. Evaluating several clinical biomarkers, we showed that PDOs recapitulated pa-",p:[0.117647,0.829656,0.852941,0.829656,0.852941,0.809283,0.117647,0.809283,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004497,0.004337,0.011801,0.009838,0.009405,0.004908,0.011596,0.008811,0.006437,0.005615,0.011459,0.009861,0.004337,0.007875,0.009336,0.009633,0.009039,0.007898,0.009405,0.005250,0.004337,0.008765,0.005250,0.005615,0.011756,0.005545,0.009108,0.009405,0.005250,0.004337,0.010820,0.005547,0.010843,0.017577,0.009085,0.007601,0.010274,0.009039,0.007624,0.007670,0.004497,0.004337,0.014518,0.009039,0.004337,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.004337,0.006620,0.011391,0.008811,0.006437,0.004337,0.011664,0.016504,0.016253,0.007670,0.004337,0.007442,0.009108,0.009108,0.008811,0.011071,0.005273,0.006163,0.011550,0.005433,0.008811,0.006209,0.009108,0.011391,0.004337,0.011368,0.009265,0.007533]},{w:"tient response to chemotherapy and targeted treatments. I.e. the most responsive PDOs ",p:[0.117647,0.850234,0.857075,0.850234,0.857075,0.829861,0.117647,0.829861,0.006437,0.005547,0.009039,0.011391,0.006437,0.004588,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004588,0.006209,0.011048,0.004588,0.008765,0.011299,0.009039,0.017485,0.010820,0.006620,0.011299,0.009039,0.007898,0.008811,0.011094,0.009724,0.004588,0.009085,0.011596,0.011391,0.004588,0.006551,0.009085,0.007624,0.009656,0.009131,0.006209,0.009108,0.011391,0.004588,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.007670,0.004497,0.004588,0.007259,0.004497,0.008743,0.004497,0.004588,0.006620,0.011299,0.009039,0.004588,0.017485,0.010957,0.007510,0.006437,0.004588,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.004588,0.011664,0.016504,0.016253,0.007670,0.004109]},{w:"in drug screening assays had been derived from patients that had better clinical response ",p:[0.117647,0.870813,0.856979,0.870813,0.856979,0.850440,0.117647,0.850440,0.005615,0.011756,0.003721,0.011391,0.007967,0.011413,0.009861,0.003721,0.007875,0.008994,0.007442,0.009108,0.009039,0.011756,0.005615,0.011459,0.009861,0.003721,0.009291,0.007533,0.007944,0.008925,0.009724,0.007670,0.003721,0.011391,0.009291,0.011391,0.003721,0.011254,0.009108,0.009039,0.011756,0.003721,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011391,0.003721,0.006414,0.007442,0.010843,0.017645,0.003721,0.011365,0.008811,0.006437,0.005549,0.009039,0.011391,0.006437,0.007670,0.003721,0.006620,0.011391,0.008811,0.006437,0.003721,0.011391,0.009291,0.011391,0.003721,0.011254,0.009128,0.006166,0.006207,0.009039,0.007807,0.003721,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009402,0.005250,0.003721,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004109]},{w:"to the same treatment. Furthermore, inter- and intra-patient drug response heterogene-",p:[0.117647,0.891392,0.852941,0.891392,0.852941,0.871019,0.117647,0.871019,0.006209,0.011048,0.004360,0.006620,0.011299,0.009039,0.004360,0.007944,0.009085,0.017485,0.009039,0.004360,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004497,0.004360,0.010729,0.011413,0.007967,0.006620,0.011299,0.009039,0.007807,0.017485,0.010843,0.007442,0.008743,0.004497,0.004360,0.005615,0.011391,0.006209,0.009039,0.007236,0.007533,0.004360,0.009085,0.011596,0.011391,0.004360,0.005615,0.011391,0.006437,0.007898,0.009291,0.007533,0.011365,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.004360,0.011391,0.007967,0.011413,0.009861,0.004360,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004360,0.011299,0.009131,0.006209,0.009039,0.007442,0.011048,0.009656,0.009039,0.011596,0.008994,0.007533]},{w:"ity was found between different PDO lines and could be partially explained by genomic ",p:[0.117647,0.911970,0.857025,0.911970,0.857025,0.891597,0.117647,0.891597,0.005273,0.006437,0.009724,0.004360,0.014723,0.009291,0.007670,0.004360,0.006026,0.010820,0.011413,0.011596,0.011391,0.004360,0.011254,0.009131,0.006437,0.014518,0.009108,0.009039,0.011756,0.004360,0.011391,0.005615,0.005969,0.005784,0.009039,0.007442,0.009039,0.011391,0.006437,0.004360,0.011664,0.016504,0.016412,0.004360,0.005250,0.005615,0.011596,0.009039,0.007670,0.004360,0.009085,0.011596,0.011391,0.004360,0.008994,0.010820,0.011550,0.005182,0.011391,0.004360,0.011251,0.009039,0.004360,0.011368,0.009085,0.007967,0.006437,0.005798,0.009405,0.005387,0.005182,0.009724,0.004360,0.009108,0.010089,0.011162,0.005433,0.009085,0.005615,0.011596,0.009108,0.011391,0.004360,0.010843,0.009724,0.004360,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.004109]},{w:"208",p:[0.083912,0.957873,0.109686,0.957873,0.109686,0.938882,0.083912,0.938882,0.008591,0.008591,0.008591]},{w:"ADDENDUM",p:[0.117647,0.067543,0.201421,0.067543,0.201421,0.045457,0.117647,0.045457,0.009679,0.010295,0.010295,0.008697,0.010706,0.010295,0.010226,0.013582]}]};